CD14 and idiopathic pulmonary fibrosis: In our validation analysis of flow cytometry data for 45 patients with idiopathic pulmonary fibrosis from the COMET trial, absolute count of CD14+ monocytes was significantly higher in patients with progressive disease compared with those with non-progressive disease (p=0·025, figure 2).